Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Dactinomycin × 90 days × Clear all

Sponsor

Conditions

Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Liquid Biopsy 1 LY3023414 1 Ifosfamide 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡